Skip to content

Supervised vs. Home Schroth Exercise in AIS

Comparative Effectiveness of Supervised vs. Home-Based Schroth Exercises in Adolescent Idiopathic Scoliosis: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07779070
Enrollment
62
Registered
2026-08-21
Start date
2026-08-31
Completion date
2027-08-31
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Idiopathic Scoliosis (AIS)

Keywords

Adolescent Idiopathic Scoliosis, Schroth Exercise

Brief summary

This study aims to compare the effectiveness of supervised Schroth exercises versus a home-based exercise program in adolescents with Adolescent Idiopathic Scoliosis (AIS).

Detailed description

Adolescent Idiopathic Scoliosis (AIS) is a three-dimensional spinal deformity that develops in children aged 10-18, affecting approximately 0.47% to 12% of this population. If left untreated, curves between 10° and 45° may progress, leading to pain, breathing difficulties, postural problems, and reduced quality of life. Although bracing and surgery are traditional options, they have limitations. Physiotherapeutic scoliosis-specific exercises (PSSE), particularly the Schroth method, are increasingly recommended as a first-line conservative treatment.

Interventions

OTHERSupervised Schroth Exercise

60-minute Schroth exercise sessions, 5 days/week for 12 weeks, delivered under one-on-one physiotherapist supervision. Includes 3D auto-correction, rotational breathing, postural stabilization, and curve-specific exercises (shoulder counter-pull, muscle cylinder, side-lying, sailing, prominent hip, Schroth walking)

OTHERHome-Based Schroth Exercise

Same 60-minute Schroth exercise program, 5 days/week for 12 weeks, performed at home without direct physiotherapist supervision. Participants receive initial instruction and an individualized exercise booklet.

Sponsors

Bitlis Eren University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The primary outcome measure, Cobb angle, will be evaluated by an experienced radiologist who is masked to the participants' group assignment.

Intervention model description

Participants will be allocated to one of two groups using block randomization: 1) Supervised Schroth Exercise Group (SSEG), or 2) Home Exercise Program Group (HEPG).

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Adolescent Idiopathic Scoliosis (idiopathic etiology) * Age between 10 and 18 years * Cobb angle between 10° and 45° * Able to participate in a 5-day/week exercise program (supervised or home-based) * Patient and parent/guardian provide written informed consent * Sufficient cooperation to comply with the study protocol and complete assessments

Exclusion criteria

* Non-idiopathic scoliosis (neuromuscular, congenital, functional, etc.) * Prior or planned spinal surgery * Neurological, rheumatological, metabolic, or cardiopulmonary disease that would interfere with participation * Brace treatment within the last 6 months or planned during the study * Regular scoliosis-specific exercise (more than 2 days/week) within the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Cobb AngleBaseline and 3 months post-interventionChange in the primary curve Cobb angle measured on standing posteroanterior full-spine radiographs, assessed at baseline and 3 months post-intervention.

Secondary

MeasureTime frameDescription
Change in Trunk Rotation Angle (ATR)Baseline and 12 weeksChange in angle of trunk rotation measured using a scoliometer during the Adam's Forward Bend Test.
Change in Thoracic KyphosisBaseline and 12 weeksChange in thoracic kyphosis angle measured using an inclinometer at T1-T2 and T12-L1 levels.
Change in Lumbar LordosisBaseline and 12 weeksChange in lumbar lordosis angle measured using an inclinometer at T12-L1 and S2-S3 levels.
Respiratory Function assessed by Spirometry (FVC, FEV1, FEV1/FVC, PEF, FEF25-75%)Baseline and 12 weeksRespiratory function will be assessed using a spirometry device. The following parameters will be recorded and analyzed: Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), the FEV1/FVC ratio, Peak Expiratory Flow (PEF), and Forced Expiratory Flow at 25-75% of FVC (FEF25-75%).
Change in Pain LevelBaseline and 12 weeksChange in musculoskeletal pain/discomfort assessed using the Turkish-validated Cornell Musculoskeletal Discomfort Questionnaire (T-CMDQ) \[19\]. The questionnaire evaluates discomfort in 18 body regions over the past week across three dimensions: frequency, severity, and functional impact on daily activities. A risk score is calculated for each body region by multiplying these three parameters. For bilaterally assessed regions, the higher of the two side-specific scores is used in the analysis. Higher scores indicate worse outcomes.
Change in Quality of LifeBaseline and 12 weeksChange in health-related quality of life assessed using the Turkish-validated Scoliosis Research Society-22 (SRS-22) questionnaire. The questionnaire consists of five domains: function, pain, self-image, mental health, and treatment satisfaction. Each item is scored from 1 (worst) to 5 (best); domain and total scores range from 1 to 5. Higher scores indicate better outcomes. The treatment satisfaction domain will be assessed only at 12 weeks; other domains assessed at both baseline and 12 weeks.

Countries

Turkey (Türkiye)

Contacts

CONTACTMesut Arslan, PhD
fzt.mesutarslan@gmail.com+90 553 674 5226

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026